Clinical Trial Results

Showing: All studies [change]
Condition: Cancer Location: Lindsay, Oklahoma 25 trials found
New Search
Filter
Trial Phase
Study Type
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
PHASE2, PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
PHASE1INTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
PHASE3INTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
PHASE1, PHASE2INTERVENTIONAL Duarte, California +4 more
RECRUITING
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer
PHASE3INTERVENTIONAL Scottsdale, Arizona +3 more
RECRUITING
Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
PHASE2, PHASE3INTERVENTIONAL Kingman, Arizona +4 more
RECRUITING
Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian Cancer
PHASE1INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
PHASE1, PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
NAINTERVENTIONAL Goodyear, Arizona +4 more
RECRUITING
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
PHASE2INTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
PHASE2INTERVENTIONAL Gilbert, Arizona +4 more
RECRUITING
Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk Women
NAINTERVENTIONAL Miami, Florida +4 more
RECRUITING
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
PHASE3INTERVENTIONAL Kingman, Arizona +4 more
RECRUITING
ctDNA Assay in Patients With Resectable Pancreatic Cancer
N/AOBSERVATIONAL Oklahoma City, Oklahoma +1 more
RECRUITING
Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors
PHASE1, PHASE2INTERVENTIONAL New Haven, Connecticut +2 more
RECRUITING
Groningen International Study on Sentinel Nodes in Vulvar Cancer-III
PHASE2INTERVENTIONAL Orange, California +4 more
RECRUITING
A Study of NX-1607 in Adults With Advanced Malignancies
PHASE1INTERVENTIONAL Duarte, California +4 more
RECRUITING
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
PHASE2INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
PHASE2, PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
N/AOBSERVATIONAL Fort Smith, Arkansas +4 more
RECRUITING
GEMINI-NSCLC: NSCLC Biomarker Study
N/AOBSERVATIONAL Birmingham, Alabama +4 more
RECRUITING
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
PHASE3INTERVENTIONAL Mobile, Alabama +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type